CDMC (Israel) and ADDS (France) signed an exclusive partnership for Safety services

CDMC- an Israeli provider of clinical data management, analysis & reporting services & ADDS- a leading European CRO and CSO (Contract Research and Safety Organization) have signed a partnership agreement

CDMC (a Bioforum Professional company), provider of clinical data management, analysis & reporting services, based in Israel, and ADDS - a leading European CRO and CSO (Contract Research and Safety Organization), based in France and in Czech Republic, have reached a partnership agreement which establishes the cooperation and allows CDMC to provide local companies clientele with ADDS's pharmacovigilance and a wide range of safety services for pre- and post-marketing.
CDMC will exclusively represent ADDS’s pharmacovigilance and Risk Management services in Israel and will allow ADDS to enjoy it’s strong presence on the local market. The companies benefit from their complementary services allowing them to provide a broader variety of services for clinical trials planning and management.
This collaboration has already proven itself and a few joint projects are in progress.

Advanced Drug Development Services (ADDS) is a European Contract Research and Safety Organization which provides full coverage of Phase II to IV clinical studies for drugs and medical devices in Europe as well as complete Pharmacovigilance and Risk Management services: including complete outsourcing of Pharmacovigilance department, European Qualified Person for Pharmacovigilance, Eudravigilance certification, safety data base and call centre.